Revolution Medicines · 9 hours ago
Associate Principal Statistical Analyst
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The Associate Principal Statistical Analyst will provide programming support and oversight for clinical programs, ensuring compliance with regulatory standards and delivering high-quality analysis.
Health CareLife ScienceMedical
Responsibilities
Provide technical oversight of statistical programming resources including contractors and CROs
Provide mentorship to future leaders to help learn and execute on RevMed core values
Ensure quality and timely delivery of analysis for statistical programming deliverables
Provide solutions by analyzing issues and problems in complex situations
Ensure accuracy of clinical trial results for internal and external audiences (e.g., regulatory authorities, academic community, and healthcare providers) via QC of documents with clinical data
Ensure that the statistical programming process conforms to the SOPs and regulatory standards where applicable
Timeline and vendor management for deliverables, including submission-related activities, complying with regulatory standards (e.g., FDA 21 CFR Part 11, GxP)
Programming support for deliverables, such as Dose Committee meetings, Investigator Brochures, publications/presentations, US, and ex-US regulatory submissions
Proficiency in regulatory standards and compliance regulations including CDISC compliance (SDTM, ADaM, define.xml, Reviewer’s Guides, etc.)
Qualification
Required
10-14 years of Statistical Programming experience in biotechnology or pharmaceutical industry
BS/BA degree or other suitable qualification with relevance to the field
Direct statistical programming experience for early or late-phase clinical trials to support production/verification of analysis datasets, tables, listings, and figures
Demonstrated ability to multi-task, prioritize options, anticipate challenges, and execute goals as a member of an interdisciplinary team is extremely important
Preferred
Early or late-stage oncology clinical trials
A demonstrable record of strong leadership and teamwork
Thrives in a collaborative team setting and is driven by a desire to deploy innovative approaches and technologies in a high energy environment
Benefits
Competitive cash compensation
Robust equity awards
Strong benefits
Significant learning and development opportunities
Company
Revolution Medicines
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
H1B Sponsorship
Revolution Medicines has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (13)
2024 (18)
2023 (15)
2022 (8)
2021 (1)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$2.25BKey Investors
Royalty PharmaBoxer CapitalNextech Invest
2025-06-24Post Ipo Debt· $250M
2024-12-02Post Ipo Equity· $750M
2023-03-02Post Ipo Equity· $323.6M
Recent News
Pharmaceutical Technology
2026-01-13
Company data provided by crunchbase